A pooled analysis of the association of isolated low levels of high-density lipoprotein cholesterol with cardiovascular mortality in Japan

[1]  K. Asayama,et al.  Combined effect of blood pressure and total cholesterol levels on long-term risks of subtypes of cardiovascular death: Evidence for Cardiovascular Prevention from Observational Cohorts in Japan. , 2015, Hypertension.

[2]  Darrel P Francis,et al.  Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117 411 patients , 2014, BMJ : British Medical Journal.

[3]  Michael J Blaha,et al.  Current guidelines for high-density lipoprotein cholesterol in therapy and future directions , 2014, Vascular health and risk management.

[4]  G. Norata,et al.  Treating high density lipoprotein cholesterol (HDL-C): quantity versus quality. , 2013, Current pharmaceutical design.

[5]  A. Tamakoshi,et al.  Relation Between Serum Total Cholesterol Level and Cardiovascular Disease Stratified by Sex and Age Group: A Pooled Analysis of 65 594 Individuals From 10 Cohort Studies in Japan , 2012, Journal of the American Heart Association.

[6]  M. Woodward,et al.  Isolated Low Levels of High-Density Lipoprotein Cholesterol Are Associated With an Increased Risk of Coronary Heart Disease: An Individual Participant Data Meta-Analysis of 23 Studies in the Asia-Pacific Region , 2011, Circulation.

[7]  R. Hui,et al.  Inverse association of plasma level of high-density lipoprotein cholesterol with intracerebral hemorrhage[S] , 2011, Journal of Lipid Research.

[8]  Gordon H Guyatt,et al.  Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis , 2009, BMJ : British Medical Journal.

[9]  J. Hokanson,et al.  The independent relationship between triglycerides and coronary heart disease , 2008, Vascular health and risk management.

[10]  K. Watson,et al.  Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting. , 2008, Journal of managed care pharmacy : JMCP.

[11]  H. Ueshima,et al.  Relation of Blood Pressure and All-Cause Mortality in 180 000 Japanese Participants: Pooled Analysis of 13 Cohort Studies , 2008, Hypertension.

[12]  Pierre Amarenco,et al.  High-density lipoprotein-cholesterol and risk of stroke and carotid atherosclerosis: a systematic review. , 2008, Atherosclerosis.

[13]  J. Genest,et al.  Effect of Obesity on High‐density Lipoprotein Metabolism , 2007, Obesity.

[14]  R. Collins,et al.  Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55 000 vascular deaths , 2007, The Lancet.

[15]  D. Lawlor,et al.  Serum cholesterol, haemorrhagic stroke, ischaemic stroke, and myocardial infarction: Korean national health system prospective cohort study , 2006, BMJ : British Medical Journal.

[16]  M. Woodward,et al.  Serum Triglycerides as a Risk Factor for Cardiovascular Diseases in the Asia-Pacific Region , 2004, Circulation.

[17]  F. Marchlinski,et al.  Right Bundle-Branch Block Ventricular Tachycardias: Septal Versus Lateral Ventricular Origin Based on Activation Time to the Right Ventricular Apex , 2004, Circulation.

[18]  Mark Woodward,et al.  Cholesterol, coronary heart disease, and stroke in the Asia Pacific region. , 2003, International journal of epidemiology.

[19]  K. Miura,et al.  High-Density Lipoprotein Cholesterol and Risk of Stroke in Japanese Men and Women: The Oyabe Study , 2003, Stroke.

[20]  J. Mckenney,et al.  National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) , 2002 .

[21]  G. Dagenais,et al.  HDL-cholesterol as a marker of coronary heart disease risk: the Québec cardiovascular study. , 2000, Atherosclerosis.

[22]  Y. Matsuzawa,et al.  Analysis of serum lipid levels in Japanese men and women according to body mass index. Increase in risk of atherosclerosis in postmenopausal women. Research Group on Serum Lipid Survey 1990 in Japan. , 1999, Atherosclerosis.

[23]  I. Puddey.  Low serum cholesterol and the risk of cerebral haemorrhage. , 1996, Atherosclerosis.

[24]  A. Folsom,et al.  High-density lipoprotein cholesterol and premature coronary heart disease in urban Japanese men. , 1994, Circulation.

[25]  M. King,et al.  Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. , 1990, Circulation.

[26]  D. Reed.  The paradox of high risk of stroke in populations with low risk of coronary heart disease. , 1990, American journal of epidemiology.

[27]  D. Jacobs,et al.  Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial. , 1989, The New England journal of medicine.

[28]  P. Wilson,et al.  High density lipoprotein cholesterol and mortality. The Framingham Heart Study. , 1988, Arteriosclerosis.

[29]  P. Wilson,et al.  Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. , 1986, JAMA.

[30]  U. Goldbourt,et al.  ASSOCIATIONS OF SERUM HIGH DENSITY LIPOPROTEIN AND TOTAL CHOLESTEROL WITH TOTAL, CARDIOVASCULAR, AND CANCER MORTALITY IN A 7-YEAR PROSPECTIVE STUDY OF 10 000 MEN , 1981, The Lancet.

[31]  H. Ueshima,et al.  Multivariate analysis of risk factors for stroke. Eight-year follow-up study of farming villages in Akita, Japan. , 1980, Preventive medicine.

[32]  M C Hjortland,et al.  High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. , 1977, The American journal of medicine.

[33]  P. Toth.  Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy , 2012 .

[34]  H. Ueshima,et al.  Population attributable numbers and fractions of deaths due to smoking: a pooled analysis of 180,000 Japanese. , 2011, Preventive medicine.

[35]  N. Unwin,et al.  Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National , 2009 .

[36]  H Tunstall-Pedoe,et al.  The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases , 2007, European Journal of Epidemiology.

[37]  S. Grundy,et al.  National Cholesterol Education Program Third Report of the National Cholesterol Education Program ( NCEP ) Expert Panel on Detection , Evaluation , and Treatment of High Blood Cholesterol in Adults ( Adult Treatment Panel III ) Final Report , 2022 .

[38]  D R Jacobs,et al.  High density lipoprotein cholesterol as a predictor of cardiovascular disease mortality in men and women: the follow-up study of the Lipid Research Clinics Prevalence Study. , 1990, American journal of epidemiology.